Date: 2015-05-12
Type of information: Nomination
Compound:
Company: Juventas Therapeutics (USA - OH)
Therapeutic area: Cardiovascular diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On May 12, 2015, Juventas Therapeutics, a clinical-stage biotechnology company focused on developing non-viral gene therapies to treat advanced cardiovascular diseases, announced that the company has expanded its Board of Directors to include James Boland as an independent director. Mr. Boland is the retired vice chairman of Ernst & Young and former president, chief executive officer and vice chairman of the Cleveland Cavaliers Operating Company. He currently serves as Chairman of JobsOhio and is on the Board of the Center for Global Business Studies in Washington D.C. Mr. Boland’s current and previous board experience also includes service on the boards of directors of Goodyear Tire and Rubber Company, Sherwin-Williams, Invacare, DDR Corp, and International Steel Group.
Financial terms:
Latest news:
